Investigation of poor predictive factors in extensive stage small cell lung cancer under etoposide-platinum-atezolizumab treatment.
Jeong Uk LimHye Seon KangAh Young ShinChang Dong YeoSung Kyoung KimJin Woo KimSeung Joon KimSang Haak LeePublished in: Thoracic cancer (2022)
In ES-SCLC under etoposide-platinum-atezolizumab, pretreatment CRP, LDH and FVC (%) were independent predictive factors.